Metraipolis › archive › dc_46fdcf1412bf
Partial Response to Nivolumab and Ipilimumab in a Patient With Malignant Pleural Mesothelioma and Pre-Existing Myasthenia Gravis Without Severe Flares or… — Europe PMC PMID:40842502
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40842502
- DOI
- 10.1002/rcr2.70297
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T12:47:51.411Z
- SHA-256 of the archived text
0ffb06b130b5f26bb25fe814a97d1e76bb9672c9c1a92cb30be0f850a4d6bc31- Stable URL of this page
https://metraipolis.com/documento/dc_46fdcf1412bf
How to cite
Partial Response to Nivolumab and Ipilimumab in a Patient With Malignant Pleural Mesothelioma and Pre-Existing Myasthenia Gravis Without Severe Flares or… — Europe PMC PMID:40842502 — Europe PMC (en), https://europepmc.org/article/MED/40842502 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_46fdcf1412bf (Metraipolis archive dc_46fdcf1412bf, sha256 0ffb06b130b5f26bb25fe814a97d1e76bb9672c9c1a92cb30be0f850a4d6bc31)
BibTeX
@misc{dc46fdcf1412bf,
title = {Partial Response to Nivolumab and Ipilimumab in a Patient With Malignant Pleural Mesothelioma and Pre-Existing Myasthenia Gravis Without Severe Flares or… — Europe PMC PMID:40842502},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40842502},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_46fdcf1412bf; sha256 0ffb06b130b5f26bb25fe814a97d1e76bb9672c9c1a92cb30be0f850a4d6bc31},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40842502. Agents can read the archived copy with the MCP tool read_document.